Describe interim safety and efficacy results from a pilot investigation of a novel, endovascular cerebrospinal fluid (CSF) shunt system for treating communicating hydrocephalus following aneurysmal subarachnoid hemorrhage (aSAH).
No takes yet. Share an insight, caveat, or question.
Lylyk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: